{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:50:33Z","timestamp":1787932233526,"version":"build-2784847793"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Wuhan Knowledge Innovation Project - Dawn Program","award":["2022020801020466"],"award-info":[{"award-number":["2022020801020466"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA014520"],"award-info":[{"award-number":["P30CA014520"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22277031"],"award-info":[{"award-number":["22277031"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFB3808200"],"award-info":[{"award-number":["2022YFB3808200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>DNA nanostructures have long been developed for biomedical purposes, but their controlled delivery in vivo proposes a major challenge for disease theranostics. We previously reported that DNA nanostructures on the scales of tens and hundreds nanometers showed preferential renal excretion or kidney retention, allowing for sensitive evaluation and effective protection of kidney function, in response to events such as unilateral ureter obstruction or acute kidney injury. Encouraged by the positive results, we redirected our focus to the liver, specifically targeting organs noticeably lacking DNA materials, to explore the interaction between DNA nanostructures and the liver. Through PET imaging, we identified SDF and M13 as DNA nanostructures exhibiting significant accumulation in the liver among numerous candidates. Initially, we investigated and assessed their biodistribution, toxicity, and immunogenicity in healthy mice, establishing the structure-function relationship of DNA nanostructures in the normal murine. Subsequently, we employed a mouse model of liver ischemia-reperfusion injury (IRI) to validate the nano-bio interactions of SDF and M13 under more challenging pathological conditions. M13 not only exacerbated hepatic oxidative injury but also elevated local apoptosis levels. In contrast, SDF demonstrated remarkable ability to scavenge oxidative responses in the liver, thereby mitigating hepatocyte injury. These compelling results underscore the potential of SDF as a promising therapeutic agent for liver-related conditions. This aimed to elucidate their roles and mechanisms in liver injury, providing a new perspective for the biomedical applications of DNA nanostructures.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s12951-024-02661-8","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T04:02:08Z","timestamp":1720065728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Liver-specific delivery of spherical DNA frameworks for alleviation of hepatic ischemic reperfusion injury"],"prefix":"10.1186","volume":"22","author":[{"given":"Hao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangmeihui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibo","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,4]]},"reference":[{"key":"2661_CR1","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nnano.2011.187","volume":"6","author":"AV Pinheiro","year":"2011","unstructured":"Pinheiro AV, Han DR, Shih WM, Yan H. Challenges and opportunities for structural DNA nanotechnology. Nat Nanotechnol. 2011;6:763\u201372.","journal-title":"Nat Nanotechnol"},{"key":"2661_CR2","doi-asserted-by":"crossref","unstructured":"Jones MR, Seeman NC, Mirkin CA. Programmable materials and the nature of the DNA bond. Science 2015, 347.","DOI":"10.1126\/science.1260901"},{"key":"2661_CR3","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1021\/jacs.2c10755","volume":"145","author":"XH Yan","year":"2023","unstructured":"Yan XH, Wang Y, Ma NN, Yu YF, Dai LZ, Tian Y. Dynamically reconfigurable DNA origami crystals driven by a designated path Diagram. J Am Chem Soc. 2023;145:3978\u201386.","journal-title":"J Am Chem Soc"},{"key":"2661_CR4","doi-asserted-by":"publisher","first-page":"e2302932","DOI":"10.1002\/smll.202302932","volume":"19","author":"D Liu","year":"2023","unstructured":"Liu D, Chen X, Jiang D, Wang C, Xia Q, Yang Y. Structural properties and Surface Modification decided pharmacokinetic behavior and Bio-distribution of DNA Origami frameworks in mice. Small. 2023;19:e2302932.","journal-title":"Small"},{"key":"2661_CR5","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/s41596-022-00754-y","volume":"18","author":"A Collins","year":"2023","unstructured":"Collins A, Moller P, Gajski G, Vodenkova S, Abdulwahed A, Anderson D, Bankoglu EE, Bonassi S, Boutet-Robinet E, Brunborg G, et al. Measuring DNA modifications with the comet assay: a compendium of protocols. Nat Protoc. 2023;18:929\u201389.","journal-title":"Nat Protoc"},{"key":"2661_CR6","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1021\/acssynbio.0c00235","volume":"9","author":"S Nummelin","year":"2020","unstructured":"Nummelin S, Shen B, Piskunen P, Liu Q, Kostiainen MA, Linko V. Robotic DNA nanostructures. ACS Synth Biol. 2020;9:1923\u201340.","journal-title":"ACS Synth Biol"},{"key":"2661_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.7150\/thno.66466","volume":"12","author":"T Shen","year":"2022","unstructured":"Shen T, Zhang Y, Mei L, Zhang XB, Zhu G. Single-stranded circular DNA theranostics. Theranostics. 2022;12:35\u201347.","journal-title":"Theranostics"},{"key":"2661_CR8","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1021\/acs.nanolett.1c04888","volume":"22","author":"Y Yang","year":"2022","unstructured":"Yang Y, Liu B, Liu Y, Chen J, Sun Y, Pan X, Xu J, Xu S, Liu Z, Tan W. DNA-Based MXFs to Enhance Radiotherapy and stimulate Robust Antitumor Immune responses. Nano Lett. 2022;22:2826\u201334.","journal-title":"Nano Lett"},{"key":"2661_CR9","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41551-018-0317-8","volume":"2","author":"DW Jiang","year":"2018","unstructured":"Jiang DW, Ge ZL, Im HJ, England CG, Ni DL, Hou JJ, Zhang LH, Kutyreff CJ, Yan YJ, Liu Y, et al. DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury. Nat Biomedical Eng. 2018;2:865\u201377.","journal-title":"Nat Biomedical Eng"},{"key":"2661_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41563-020-00824-0","volume":"20","author":"SL Liu","year":"2021","unstructured":"Liu SL, Jiang Q, Zhao X, Zhao RF, Wang YN, Wang YM, Liu JB, Shang YX, Zhao S, Wu TT, et al. A DNA nanodevice-based vaccine for cancer immunotherapy (sep, 10.1038\/s41563-020-0793-6, 2020). Nat Mater. 2021;20:431\u20133.","journal-title":"Nat Mater"},{"key":"2661_CR11","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/s41565-021-00988-z","volume":"16","author":"C Cui","year":"2021","unstructured":"Cui C, Chakraborty K, Tang XA, Schoenfelt KQ, Hoffman A, Blank A, McBeth B, Pulliam N, Reardon CA, Kulkarni SA, et al. A lysosome-targeted DNA nanodevice selectively targets macrophages to attenuate tumours. Nat Nanotechnol. 2021;16:1394\u2013U1122.","journal-title":"Nat Nanotechnol"},{"key":"2661_CR12","doi-asserted-by":"crossref","unstructured":"Yao GB, Zhang F, Wang F, Peng TH, Liu H, Poppleton E, Sulc P, Jiang SX, Liu L, Gong C et al. vol 12, pg 1067, : Meta-DNA structures (2020). Nature Chemistry 2021, 13:614\u2013614.","DOI":"10.1038\/s41557-020-00611-z"},{"key":"2661_CR13","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1021\/acs.accounts.0c00323","volume":"53","author":"D Jiang","year":"2020","unstructured":"Jiang D, Rosenkrans ZT, Ni D, Lin J, Huang P, Cai W. Nanomedicines for Renal Management: from imaging to treatment. Acc Chem Res. 2020;53:1869\u201380.","journal-title":"Acc Chem Res"},{"key":"2661_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nnano.2012.73","volume":"7","author":"H Lee","year":"2012","unstructured":"Lee H, Lytton-Jean AKR, Chen Y, Love KT, Park AI, Karagiannis ED, Sehgal A, Querbes W, Zurenko CS, Jayaraman M, et al. Molecularly self-assembled nucleic acid nanoparticles for targeted siRNA delivery. Nat Nanotechnol. 2012;7:389\u201393.","journal-title":"Nat Nanotechnol"},{"key":"2661_CR15","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/s11426-016-5596-x","volume":"59","author":"J Chao","year":"2016","unstructured":"Chao J, Zhang YN, Zhu D, Liu B, Cui CJ, Su S, Fan CH, Wang LH. Hetero-assembly of gold nanoparticles on a DNA origami template. Sci China-Chemistry. 2016;59:730\u20134.","journal-title":"Sci China-Chemistry"},{"key":"2661_CR16","doi-asserted-by":"publisher","first-page":"10000","DOI":"10.1002\/adma.201601710","volume":"28","author":"Y Du","year":"2016","unstructured":"Du Y, Jiang Q, Beziere N, Song LL, Zhang Q, Peng D, Chi CW, Yang X, Guo HB, Diot G, et al. DNA-Nanostructure-gold-nanorod hybrids for enhanced in vivo Optoacoustic Imaging and Photothermal Therapy. Adv Mater. 2016;28:10000\u20137.","journal-title":"Adv Mater"},{"key":"2661_CR17","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1021\/acs.chemrev.7b00663","volume":"119","author":"Q Hu","year":"2019","unstructured":"Hu Q, Li H, Wang L, Gu H, Fan C. DNA nanotechnology-enabled drug Delivery systems. Chem Rev. 2019;119:6459\u2013506.","journal-title":"Chem Rev"},{"key":"2661_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/nbt.4071","volume":"36","author":"SP Li","year":"2018","unstructured":"Li SP, Jiang Q, Liu SL, Zhang YL, Tian YH, Song C, Wang J, Zou YG, Anderson GJ, Han JY, et al. A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger. Nat Biotechnol. 2018;36:258\u201364.","journal-title":"Nat Biotechnol"},{"key":"2661_CR19","doi-asserted-by":"publisher","first-page":"e202111980","DOI":"10.1002\/anie.202111980","volume":"61","author":"H Wang","year":"2022","unstructured":"Wang H, Liu Q, Lan X, Jiang D. Framework nucleic acids in Nuclear Medicine Imaging: shedding light on Nano-Bio interactions. Angew Chem Int Ed Engl. 2022;61:e202111980.","journal-title":"Angew Chem Int Ed Engl"},{"key":"2661_CR20","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1021\/acs.bioconjchem.5b00680","volume":"27","author":"J Li","year":"2016","unstructured":"Li J, Jiang D, Bao B, He Y, Liu L, Wang X. Radiolabeling of DNA bipyramid and preliminary Biological evaluation in mice. Bioconjug Chem. 2016;27:905\u201310.","journal-title":"Bioconjug Chem"},{"key":"2661_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2165\/00003088-199528010-00002","volume":"28","author":"S Agrawal","year":"1995","unstructured":"Agrawal S, Temsamani J, Galbraith W, Tang J. Pharmacokinetics of antisense oligonucleotides. Clin Pharmacokinet. 1995;28:7\u201316.","journal-title":"Clin Pharmacokinet"},{"key":"2661_CR22","first-page":"60","volume":"209","author":"S Agrawal","year":"1997","unstructured":"Agrawal S, Zhang R. Pharmacokinetics of oligonucleotides. Ciba Found Symp. 1997;209:60\u201375. discussion 75\u2009\u2013\u200968.","journal-title":"Ciba Found Symp"},{"key":"2661_CR23","doi-asserted-by":"publisher","first-page":"7595","DOI":"10.1073\/pnas.88.17.7595","volume":"88","author":"S Agrawal","year":"1991","unstructured":"Agrawal S, Temsamani J, Tang JY. Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. Proc Natl Acad Sci U S A. 1991;88:7595\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2661_CR24","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.1021\/acsami.5b10792","volume":"8","author":"D Jiang","year":"2016","unstructured":"Jiang D, Sun Y, Li J, Li Q, Lv M, Zhu B, Tian T, Cheng D, Xia J, Zhang L, et al. Multiple-armed tetrahedral DNA nanostructures for Tumor-Targeting, Dual-Modality in vivo imaging. ACS Appl Mater Interfaces. 2016;8:4378\u201384.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2661_CR25","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s12274-019-2271-5","volume":"12","author":"D Jiang","year":"2019","unstructured":"Jiang D, Im HJ, Boleyn ME, England CG, Ni D, Kang L, Engle JW, Huang P, Lan X, Cai W. Efficient renal clearance of DNA tetrahedron nanoparticles enables quantitative evaluation of kidney function. Nano Res. 2019;12:637\u201342.","journal-title":"Nano Res"},{"key":"2661_CR26","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41551-018-0317-8","volume":"2","author":"D Jiang","year":"2018","unstructured":"Jiang D, Ge Z, Im HJ, England CG, Ni D, Hou J, Zhang L, Kutyreff CJ, Yan Y, Liu Y, et al. DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury. Nat Biomed Eng. 2018;2:865\u201377.","journal-title":"Nat Biomed Eng"},{"key":"2661_CR27","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/nmat4718","volume":"15","author":"KM Tsoi","year":"2016","unstructured":"Tsoi KM, MacParland SA, Ma XZ, Spetzler VN, Echeverri J, Ouyang B, Fadel SM, Sykes EA, Goldaracena N, Kaths JM, et al. Mechanism of hard-nanomaterial clearance by the liver. Nat Mater. 2016;15:1212\u201321.","journal-title":"Nat Mater"},{"key":"2661_CR28","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","volume":"240","author":"YN Zhang","year":"2016","unstructured":"Zhang YN, Poon W, Tavares AJ, McGilvray ID, Chan WCW. Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination. J Control Release. 2016;240:332\u201348.","journal-title":"J Control Release"},{"key":"2661_CR29","doi-asserted-by":"publisher","first-page":"8767","DOI":"10.1021\/acsnano.3c02102","volume":"17","author":"R Yan","year":"2023","unstructured":"Yan R, Cui W, Ma W, Li J, Liu Z, Lin Y. Typhaneoside-Tetrahedral Framework nucleic acids system: mitochondrial recovery and antioxidation for acute kidney Injury treatment. ACS Nano. 2023;17:8767\u201381.","journal-title":"ACS Nano"},{"key":"2661_CR30","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/anie.201810735","volume":"58","author":"M Li","year":"2019","unstructured":"Li M, Wang C, Di Z, Li H, Zhang J, Xue W, Zhao M, Zhang K, Zhao Y, Li L. Engineering multifunctional DNA hybrid nanospheres through coordination-driven self-assembly. Angew Chem Int Ed Engl. 2019;58:1350\u20134.","journal-title":"Angew Chem Int Ed Engl"},{"key":"2661_CR31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","volume":"15","author":"M Locati","year":"2020","unstructured":"Locati M, Curtale G, Mantovani A. Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev Pathol. 2020;15:123\u201347.","journal-title":"Annu Rev Pathol"},{"key":"2661_CR32","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1038\/emm.2013.135","volume":"46","author":"DI Cho","year":"2014","unstructured":"Cho DI, Kim MR, Jeong HY, Jeong HC, Jeong MH, Yoon SH, Kim YS, Ahn Y. Mesenchymal stem cells reciprocally regulate the M1\/M2 balance in mouse bone marrow-derived macrophages. Exp Mol Med. 2014;46:e70.","journal-title":"Exp Mol Med"},{"key":"2661_CR33","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","volume":"23","author":"A Mantovani","year":"2002","unstructured":"Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002;23:549\u201355.","journal-title":"Trends Immunol"},{"key":"2661_CR34","doi-asserted-by":"crossref","unstructured":"Li MY, Yang YH, Xiong LT, Jiang P, Wang JJ, Li CX. Metabolism, metabolites, and macrophages in cancer. J Hematol Oncol 2023, 16.","DOI":"10.1186\/s13045-023-01478-6"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02661-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-024-02661-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02661-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T04:04:16Z","timestamp":1720065856000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-024-02661-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,4]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2661"],"URL":"https:\/\/doi.org\/10.1186\/s12951-024-02661-8","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,4]]},"assertion":[{"value":"31 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Weibo Cai declares conflict of interest with the following corporations: Actithera, Inc., Rad Source Technologies, Inc., Portrai, Inc., rTR Technovation Corporation, and Four Health Global Pharmaceuticals Inc. All other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"394"}}